Traders Witness Possible Short Squeezes in ROSG and OSIR
Tweet Send to a Friend
Up)
Traders are chatting about a couple potential short squeezes being witnessed in ROSG and OSIR:
Rosetta Genomics, Ltd. (Nasdaq: ROSG) - up 18 percent today, and 585 percent since announcing on May 16th that medicare will cover its miRviews mets. Shares have drifted lower over the past week or so.
Osiris Therapeutics, Inc. (Nasdaq: OSIR) - up 14 percent today and 49 percent since announcing consent in New Zealand to market its first-in-class stem cell therapy Prochymal.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Rosetta Genomics, Ltd. (Nasdaq: ROSG) - up 18 percent today, and 585 percent since announcing on May 16th that medicare will cover its miRviews mets. Shares have drifted lower over the past week or so.
Osiris Therapeutics, Inc. (Nasdaq: OSIR) - up 14 percent today and 49 percent since announcing consent in New Zealand to market its first-in-class stem cell therapy Prochymal.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- Silver Wheaton (SLW) Halt Also Likely Related to Barrick's Pascua-Lama Project
- InterOil (IOC) Enters negotiations with ExxonMobil (XOM) on Development Of The Elk And Antelope Resource
Create E-mail Alert Related Categories
Momentum Movers, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
